These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate. Moore S, Khalaj AJ, Patel R, Yoon J, Ichwan D, Hayardeny L, Tiwari-Woodruff SK. J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965 [Abstract] [Full Text] [Related]
3. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. Arnon R, Aharoni R. J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693 [Abstract] [Full Text] [Related]
5. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R. J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [Abstract] [Full Text] [Related]
6. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis. Gentile A, Musella A, Bullitta S, Fresegna D, De Vito F, Fantozzi R, Piras E, Gargano F, Borsellino G, Battistini L, Schubart A, Mandolesi G, Centonze D. J Neuroinflammation; 2016 Aug 26; 13(1):207. PubMed ID: 27566665 [Abstract] [Full Text] [Related]
7. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis. Musumeci G, Grasselli G, Rossi S, De Chiara V, Musella A, Motta C, Studer V, Bernardi G, Haji N, Sepman H, Fresegna D, Maccarrone M, Mandolesi G, Centonze D. Neurobiol Dis; 2011 Sep 26; 43(3):669-77. PubMed ID: 21672630 [Abstract] [Full Text] [Related]
20. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis. Aharoni R, Eilam R, Lerner S, Shavit-Stein E, Dori A, Chapman J, Arnon R. Int J Mol Sci; 2021 Dec 14; 22(24):. PubMed ID: 34948217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]